Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

Antoniou, A., Pharoah, P.D.P., Narod, S., Risch, H.A., Eyfjord, J.E., Hopper, J.L., Loman, N., Olsson, H. +25 more·2003·The American Journal of Human Genetics
DOI 10.1086/375033

Cited by (1,009)

Items 601–700 of 1,009

  1. Review of risk factors for the development of contralateral breast cancer
    Ingrid Marie Lizarraga, Sonia L. Sugg, Ronald J. Weigel, Carol E. H. Scott‐Conner · 2013 · The American Journal of Surgery
  2. CLCA2 tumour suppressor gene in 1p31 is epigenetically regulated in breast cancer
    Xiurong Li, John Kenneth Cowell, Khalid Sossey‐Alaoui · 2004 · Oncogene
  3. Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK
    Susanne F. Meisel, Nora Pashayan, Belinda Rahman, Lucy E. Side, Lindsay Sarah Macduff Fraser, Sue Gessler, Anne Lanceley, Jane Wardle · 2015 · The Breast
  4. Fertility treatments and invasive epithelial ovarian cancer risk in Jewish Israeli BRCA1 or BRCA2 mutation carriers
    Tamar Perri, Dror Lifshitz, Siegal Sadetzki, Bernice Oberman, Dror Meirow, Gilad Ben‐Baruch, Eitan Friedman, Jacob Korach · 2015 · Fertility and Sterility
  5. Frequent mismatch-repair defects link prostate cancer to Lynch syndrome
    Mev Dominguez–Valentin, Patrick Joost, Christina Therkildsen, Mats Jönsson, Eva Rambech, Mef Christina Nilbert · 2016 · BMC Urology
  6. Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: A pilot study in women with BRCA1/2 mutations
    Denise R. Nebgen, Jean A. Hurteau, Laura L. Holman, Andrea Michele Bradford, Mark F. Munsell, Beth R. Soletsky, Charlotte C. Sun, Gary B. Chisholm, Karen H. Lu · 2018 · Gynecologic Oncology
  7. Short‐ and Long‐Term Impact of Receiving Genetic Mutation Results in Women at Increased Risk for Hereditary Breast Cancer
    Jacqueline R. Lim, Mariette Macluran, Melanie Anne Price, Barbara Kaye Bennett, Phyllis Noemi Butow, kConFab Psychosocial Group · 2004 · Journal of Genetic Counseling
  8. Shaping the BRCAness mutational landscape by alternative double-strand break repair, replication stress and mitotic aberrancies
    Colin Stok, Yannick P. Kok, Nathalie van den Tempel, Marcel A.T.M. van Vugt · 2021 · Nucleic Acids Research
  9. The appraisal and management of uncertainty: Implications for information-retrieval systems
    Dale E. Brashers, Timothy P. Hogan · 2013 · Information Processing & Management
  10. BRCA and Early Events in the Development of Serous Ovarian Cancer
    Sophia H.L. George, Patricia H. Shaw · 2014 · Frontiers in Oncology
  11. Diagnosis of breast cancer in women age 40 and younger: delays in diagnosis result from underuse of genetic testing and breast imaging
    Srila Samphao, Amanda J. Wheeler, Elizabeth A. Rafferty, James Selib Michaelson, Michelle Connolly Specht, Michele A. Gadd, Kevin S. Hughes, Barbara Lynn Smith · 2009 · The American Journal of Surgery
  12. Age of onset in familial cancer
    Andreas Brandt, Justo Lorenzo Bermejo, Jan Sundquist, Kari Hemminki · 2008 · Annals of Oncology
  13. Saving the spandrels? Adaptive genomic variation in conservation and fisheries management
    Devon E. Pearse · 2016 · Journal of Fish Biology
  14. Racial health disparities in ovarian cancer: not just black and white
    Sanjeev K. Srivastava, Aamir Ahmad, Orlandric Miree, Girijesh Kumar Patel, Seema Singh, Rodney Paul Rocconi, Ajay P. Singh · 2017 · Journal of Ovarian Research
  15. Genetic Epidemiology of Breast Cancer in Latin America
    Valentina A. Zavala, Silvia Juliana Serrano-Gomez, Julie Dutil, Laura Fejerman · 2019 · Genes
  16. Effect of Mammography on Breast Cancer Risk in Women with Mutations in BRCA1 or BRCA2
    Deborah J. Goldfrank, Shannon Chuai, Jonine L. Bernstein, Teresa Ramón y Cajal, Johanna B. Lee, M. Carmen Alonso, Orland Dı́ez, Monserrat Baiget, Noah D. Kauff, Kenneth Offit et al. · 2006 · Cancer Epidemiology Biomarkers & Prevention
  17. Common risk factors of breast and ovarian cancer: recent view
    George Zografos, Μάριος Πάνου, Nikol Panou · 2004 · International Journal of Gynecological Cancer
  18. Are we overestimating the penetrance of mutations in SDHB?
    Francesca Schiavi, Roger Laughlin Milne, Emma Anda, Pilar Blay, Maurizio Castellano, Giuseppe Opocher, Mercedes Robledo, Alberto Cascón · 2010 · Human Mutation
  19. A Decade of Advances in Treatment for Advanced Non–Small Cell Lung Cancer
    Scott N. Gettinger, Thomas James Lynch · 2011 · Clinics in Chest Medicine
  20. Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer
    Daniel Trujillano, Maximilian E. R. Weiss, Juliane Schneider, Julia Köster, Efstathios B. Papachristos, Viatcheslav Saviouk, Tetyana Zakharkina, Nahid Nahavandi, Lejla Kovačević, Arndt Rolfs · 2014 · Journal of Molecular Diagnostics
  21. PARP inhibitors in platinum-sensitive high-grade serous ovarian cancer
    Robert David Morgan, Andrew R. Clamp, D. Gareth Evans, Richard John Edmondson, Gordon C. Jayson · 2018 · Cancer Chemotherapy and Pharmacology
  22. The Translational Status of Cancer Liquid Biopsies
    Siniša Bratulić, Francesco Gatto, Jens Nielsen · 2019 · Regenerative Engineering and Translational Medicine
  23. Racial/ethnic disparities in ovarian cancer research
    Lauren Cole Peres, Joellen M. Schildkraut · 2020 · Advances in cancer research
  24. Prophylactic Mastectomy and Reconstruction: Clinical Outcomes and Patient Satisfaction
    Scott L. Spear, Karl A. Schwarz, Mark L. Venturi, Todd Barbosa, Ali A. Alattar · 2008 · Plastic & Reconstructive Surgery
  25. Returning a Genomic Result for an Adult-Onset Condition to the Parents of a Newborn: Insights From the BabySeq Project
    Ingrid A. Holm, Amy L. McGuire, Stacey Pereira, Heidi L. Rehm, Robert C. Green, Alan H. Beggs, and the BabySeq Project Team · 2019 · PEDIATRICS
  26. Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
    Rick A.C.M. Boonen, Amélie Rodrigue, Chantal Stoepker, Wouter W. Wiegant, Bas Vroling, Milan Sharma, Magdalena B. Rother, Nandi Celosse, Maaike P.G. Vreeswijk, Fergus J. Couch et al. · 2019 · Nature Communications
  27. Pathology of Hereditary Breast and Ovarian Cancer
    Anjelica Hodgson, Gulisa Turashvili · 2020 · Frontiers in Oncology
  28. Prophylactic Bilateral Salpingo-Oophorectomy Compared With Surveillance in Women With BRCA Mutations
    Kathleen M. Schmeler, Charlotte C. Sun, Diane C. Bodurka, Kristin G. White, Pamela T. Soliman, Anne R. Uyei, Julie Erlichman, Banu Arun, Molly S. Daniels, Susan A. Rimes et al. · 2006 · Obstetrics and Gynecology
  29. BRCA mutations in the manifestation and treatment of ovarian cancer
    Zimin Pan, Xing Xie · 2017 · Oncotarget
  30. How Far Do We Go With Genetic Evaluation? Gene, Panel, and Tumor Testing
    Filipa C. Lynce, Claudine J. Isaacs · 2016 · American Society of Clinical Oncology Educational Book
  31. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru
    Julio E. Abugattas, Marcia Llacuachaqui, Yasser Sullcahuamán Allende, A. Arias Velásquez, Raúl G. Velarde, Jose Manuel Cotrina, Milko Garcés, M.L. Villalobos León, G. Calderón, M. de la Cruz et al. · 2014 · Clinical Genetics
  32. Risk factors and epidemiology of breast cancer
    Elinor Washbrook · 2006 · Women s Health Medicine
  33. Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer
    The WECARE Collaborative Study Group, Kerryn W. Reding, Jonine L. Bernstein, Bryan M. Langholz, Leslie Bernstein, Robert W. Haile, Colin B. Begg, Charles F. Lynch, PATRICK J. CONCANNON, Åke Borg et al. · 2010 · Breast Cancer Research and Treatment
  34. Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: A population‐based study
    Aliki Taylor, D. Winter, Charles A. Stiller, Mike F Murphy, Mike Hawkins · 2006 · International Journal of Cancer
  35. BRCA Gene Structure and Function in Tumor Suppression
    Conleth G. Murphy, Mary Ellen Moynahan · 2010 · The Cancer Journal
  36. BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression
    M. Yan, Mukta Rayoo, Elena A. Takano, Heather Thorne, Stephen B. Fox · 2009 · British Journal of Cancer
  37. Genetic Testing by Cancer Site
    Scott M. Weissman, Shelly M. Weiss, Anna C. Newlin · 2012 · The Cancer Journal
  38. Verification of consumers' experiences and perceptions of genetic discrimination and its impact on utilization of genetic testing
    Kristine K Barlow-Stewart, Sandra D. Taylor, Susan A. Treloar, Mark Stranger, Margaret F. A. Otlowski · 2009 · Genetics in Medicine
  39. Factors Associated with an Individual's Decision to Withdraw from Genetic Testing for Breast And Ovarian Cancer Susceptibility: Implications for Counseling
    Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard · 2007 · Genetic Testing
  40. Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: A critical review of the literature
    Jan C. Drooger, Maartje J. Hooning, Caroline Seynaeve, Margreet H.A. Baaijens, Inge Marie Obdeijn, Stefan Sleijfer, Agnes Jager · 2014 · Cancer Treatment Reviews
  41. A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effects
    Sarah Jervis, Honglin Song, Andrew Lee, Ed Dicks, Patricia A. Harrington, Caroline Baynes, Ranjit Manchanda, Douglas F. Easton, Ian J. Jacobs, Paul D.P. Pharoah et al. · 2015 · Journal of Medical Genetics
  42. Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the “Angelina Jolie Effect”
    Christine Staudigl, Georg Pfeiler, Katharina Hrauda, Romana Renz, Andreas Berger, Renate Lichtenschopf, Christian Fridolin Singer, Muy-Kheng Maria Tea · 2016 · BMC Cancer
  43. Impact of risk-reducing salpingo-oophorectomy in premenopausal women
    Vermeulen, R. F. M., Beurden, M. van, Korse, C. M., Kenter, G. G. · 2017 · Climacteric
  44. Variant classification changes over time in BRCA1 and BRCA2
    Chloe E. Mighton, George S. Charames, Marina Wang, Kathleen-Rose Zakoor, Andrew Wong, Salma Shickh, Nicholas Watkins, Matthew S. Lebo, Yvonne Bombard, Jordan P. Lerner‐Ellis · 2019 · Genetics in Medicine
  45. BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study
    Þórunn Rafnar, Kristrún R. Benediktsdóttir, Bjarki Eldon, Thorgeir Gestsson, Hafsteinn Saemundsson, Karl Olafsson, Anna Salvarsdottir, Eirı́kur Steingrı́msson, Steinunn Thorlacius · 2004 · European Journal of Cancer
  46. The ?portrait? of hereditary breast cancer
    Marc Lacroix, Guy Leclercq · 2005 · Breast Cancer Research and Treatment
  47. Evaluation of models to predict BRCA germline mutations
    kConFab Investigators, H H Kang, Rachel Williams, J Leary, Clare L. Ringland, Judy Kirk, Robyn Lynne Ward · 2006 · British Journal of Cancer
  48. Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations
    Fabio Marroni, Paolo Aretini, Emma D’Andrea, Maria Adelaide Caligo, Laura Cortesi, Alessandra Viel, Enrico Ricevuto, Marco Montagna, Giovanna Cipollini, Massimo Federico et al. · 2004 · European Journal of Human Genetics
  49. Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer
    Brita Wasteson Arver, Karin Isaksson, Hans Atterhem, Annika Baan, Leif Bergkvist, Yvonne Brandberg, Hans Ehrencrona, Monica Emanuelsson, Henrik Hellborg, Karin Maria Henriksson et al. · 2011 · Annals of Surgery
  50. The RAD51 135 G>C Polymorphism Modifies Breast Cancer and Ovarian Cancer Risk in Polish BRCA1 Mutation Carriers
    Anna Jakubowska, Jacek Gronwald, Janusz Menkiszak, Bohdan Górski, Tomasz Huzarski, Tomasz Byrski, Lutz Edler, Jan Lubiński, Rodney John Scott, Ute Hamann · 2007 · Cancer Epidemiology Biomarkers & Prevention
  51. The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety
    Erica Sermijn, Liesbeth M. Delesie, Ellen Deschepper, Ingrid Pauwels, M Bonduelle, Erik Teugels, Jacques De Grève · 2016 · Familial Cancer
  52. BRCA1 promoter methylation in peripheral blood is associated with the risk of triple‐negative breast cancer
    Karolina Prajzendanc, Paweł Domagała, Jolanta Hybiak, Janusz Ryś, Tomasz Huzarski, Marek Szwiec, Joanna Tomiczek‐Szwiec, Wojciech Redelbach, Aleksandra Sejda, Jacek Gronwald et al. · 2019 · International Journal of Cancer
  53. Genetic counselors: translating genomic science into clinical practice
    Robin L. Bennett, Heather L. Hampel, Jessica B. Mandell, Joan H. Marks · 2003 · Journal of Clinical Investigation
  54. Reproductive Issues for Women With BRCA Mutations
    Lois C. Friedman · 2005 · JNCI Monographs
  55. Left-Right Asymmetry in Embryonic Development and Breast Cancer: Common Molecular Determinants?
    Jörg Wilting, Martin Hagedorn · 2011 · Current Medicinal Chemistry
  56. Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer
    Susan M. Domchek, Komal L. Jhaveri, Sujata N Patil, Jill E. Stopfer, Clifford A. Hudis, Jacquelyn M. Powers, Zsofia Kinga Stadler, Laura Goldstein, Noah D. Kauff, Mustafa Khasraw et al. · 2012 · Cancer
  57. BRCA1 and BRCA2: The genetic testing and the current management options for mutation carriers
    Marzia Palma, Elisabetta Ristori, Enrico Ricevuto, Giuseppe Giannini, Alberto Gulino · 2005 · Critical Reviews in Oncology/Hematology
  58. Prevention of ovarian cancer
    Louise Hanna, Malcolm Adams · 2005 · Best Practice & Research Clinical Obstetrics & Gynaecology
  59. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation
    Kelly A. Metcalfe, William David Foulkes, Charmaine Kim‐Sing, Peter Ainsworth, Barry P. Rosen, Susan Randall Armel, Aletta Poll, Andrea F. Eisen, Dawna M. Gilchrist, Albert E. Chudley et al. · 2008 · Clinical Genetics
  60. Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma
    Marián Novak, Jenny Lester, Alison M. Karst, Vinita Parkash, Michelle S. Hirsch, Christopher P. Crum, Beth Y. Karlan, Ronny Drapkin · 2015 · Gynecologic Oncology
  61. Antimüllerian hormone levels are lower in BRCA2 mutation carriers
    Lauren N. C. Johnson, Mary Dupuis Sammel, Susan M. Domchek, Allison Schanne, Maureen Prewitt, Clarisa R. Gracia · 2017 · Fertility and Sterility
  62. Impact of Bilateral Prophylactic Mastectomy and Immediate Reconstruction on Health-Related Quality of Life in Women at High Risk for Breast Carcinoma: Results of the Mastectomy Reconstruction Outcomes Consortium Study
    Colleen M. McCarthy, Jennifer B. Hamill, Hyungjin Myra Kim, Ji Qi, Edwin G. Wilkins, Andrea L. Pusic · 2017 · Annals of Surgical Oncology
  63. Mechanisms of DNA damage repair in adult stem cells and implications for cancer formation
    Clare E. Weeden, Marie-Liesse Asselin-Labat · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  64. The Indenoisoquinoline TOP1 Inhibitors Selectively Target Homologous Recombination-Deficient and Schlafen 11-Positive Cancer Cells and Synergize with Olaparib
    Marzi, Laetitia, Szabova, Ludmila, Gordon, Melanie, Weaver Ohler, Zoe, Sharan, Shyam K., Beshiri, Michael L., Etemadi, Moudjib, Murai, Junko, Kelly, Kathleen, Pommier, Yves · 2019 · Clinical Cancer Research
  65. Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer
    Lisa Jay Kessler, Aliya Collier, Kiyona Brewster, C.H. Smith, Benita Weathers, E. Paul Wileyto, Chanita Hughes Halbert · 2005 · Genetics in Medicine
  66. Homologous Recombination and Replication Fork Protection: BRCA2 and More!
    Weiran Feng, Maria Jasin · 2017 · Cold Spring Harbor Symposia on Quantitative Biology
  67. Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care
    Leigha A. Senter, David M. O’Malley, Floor Jenniskens Backes, Larry J. Copeland, Jeffery M. Fowler, Ritu Salani, David E. Cohn · 2017 · Gynecologic Oncology
  68. Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
    Daniel Martin Klotz, Pauline Wimberger · 2017 · Archives of Gynecology and Obstetrics
  69. Surgical prevention strategies in ovarian cancer
    Adrianne Rose Mallen, Thing Rinda Soong, Mary K. Townsend, Robert Michael Wenham, Christopher P. Crum, Shelley S. Tworoger · 2018 · Gynecologic Oncology
  70. Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: A prospective cohort study
    Kristin Bosse, Kerstin Rhiem, Barbara Wappenschmidt, Martin Hellmich, Martin Madeja, Monika Ortmann, Peter K Mallmann, Rita K. Schmutzler · 2006 · Gynecologic Oncology
  71. Tumor characteristics as an analytic tool for classifying genetic variants of uncertain clinical significance
    Robert M.W. Hofstra, Amanda B. Spurdle, Diana Eccles, William D. Foulkes, Niels de Wind, Nicoline Hoogerbrugge, Frans B.L. Hogervorst, Georgia Chenevix‐Trench · 2008 · Human Mutation
  72. Gerosuppressant Metformin: less is more
    Javier Abel Menéndez, Sílvia Cufí, Cristina Oliveras‐Ferraros, Luciano Vellón, Jorge Joven, Alejandro Vázquez‐Martín · 2011 · Aging
  73. Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study
    Eva Blondeaux, Amir Sonnenblick, Elisa Agostinetto, Raphaëlle Bas, Hee Jeong Kim, Maria Alice Franzoi, Rinat Bernstein‐Molho, Sabine C. Linn, Ava Kwong, Katarzyna Pogoda et al. · 2025 · The Lancet Oncology
  74. Hereditary ovarian cancer and two-compartment tumor metabolism
    Ubaldo Martinez‐Outschoorn, Renee M. Balliet, Lin Zhao, Diana Whitaker‐Menezes, Anthony Howell, Federica Sotgia, Michael P. Lisanti · 2012 · Cell Cycle
  75. Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations
    Mara Colombo, Giovanna De Vecchi, Laura Caleca, Claudia Foglia, Carla Barbara Ripamonti, Filomena Ficarazzi, Monica Barile, Liliana Varesco, Bernard Peissel, Siranoush Manoukian et al. · 2013 · PLoS ONE
  76. Breast cancer susceptibility testing: past, present and future
    Jessica Goldberg, Patrick Ivan Borgen · 2006 · Expert Review of Anticancer Therapy
  77. Modification ofBRCA1-Associated Breast and Ovarian Cancer Risk byBRCA1-Interacting Genes
    Timothy Richard Rebbeck, Nandita Mitra, Susan M. Domchek, Fei Wan, Tara M. Friebel, Teo V. Tran, Christian Fridolin Singer, Muy-Kheng Maria Tea, Joanne L. Blum, Nadine Tung et al. · 2011 · Cancer Research
  78. Challenging and Complex Decisions in the Management of the BRCA Mutation Carrier
    Daniela L Stan, Lynne T. Shuster, Myra J. Wick, Casey L. Swanson, Sandhya Pruthi, Jamie Nadine Bakkum-Gamez · 2013 · Journal of Women s Health
  79. Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer
    S. Percy Ivy, Joyce F. Liu, Jung‐Min Lee, Ursula A. Matulonis, Elise C. Kohn · 2016 · Expert Opinion on Investigational Drugs
  80. Genomic Disparities in Breast Cancer among Latinas
    Filipa C. Lynce, Kristi D. Graves, Lina H. Jandorf, Charite Nicolette Ricker, Eida Castro, Laura Moreno, Bianca M. Augusto, Laura Fejerman, Susan Thomas Vadaparampil · 2016 · Cancer Control
  81. Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer
    Sana Intidhar Labidi‐Galy, Timothée Olivier, Manuel Jorge Rodrigues, Domenico Ferraioli, Olfa Derbel, Alexandre Bodmer, Patrick Petignat, Beata Rak, Nicolas Chopin, Olivier Trédan et al. · 2017 · Clinical Cancer Research
  82. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation
    Rafael Canfield Brianese, Kivvi Duarte de Mello Nakamura, Fernanda G. S. R. Almeida, Rodrigo Fernandes Ramalho, Bruna Durães de Figueiredo Barros, Elisa Napolitano Ferreira, Maria Nirvana Formiga, Victor Piana de Andrade, Vladmir Cláudio Cordeiro de Lima, Dirce Maria Carraro · 2017 · Breast Cancer Research and Treatment
  83. Oncologist-led BRCA ‘mainstreaming’ in the ovarian cancer clinic: A study of 255 patients and its impact on their management
    Megan Rumford, Mark Peter Lythgoe, Iain A. McNeish, Hani Gabra, Laura A. Tookman, Nazneen Rahman, Angela Joy George, Jonathan Krell · 2020 · Scientific Reports
  84. What’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer
    Sandra van Dijk, Wilma Otten, Daniëlle R. M. Timmermans, Christie J. van Asperen, Hanne E.J. Meijers-Heijboer, Aad Tibben, Martijn H. Breuning, Job Kievit · 2005 · Genetics in Medicine
  85. On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls
    Dominic Varga · 2006 · Mutagenesis
  86. A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity
    Jennifer Keating Litton, Marion Elizabeth Scoggins, David Luis Ramirez, Rashmi Krishna Murthy, Gary J. Whitman, Kenneth R. Hess, Beatriz Elena Adrada, Stacy L. Moulder, Carlos Hernando Barcenas, Vicente Valero et al. · 2017 · npj Breast Cancer
  87. Characterization of BRCA1 Protein Targeting, Dynamics, and Function at the Centrosome
    Kirsty M. Brodie, Beric R. Henderson · 2012 · Journal of Biological Chemistry
  88. Survival of patients with BRCA1-associated breast cancer diagnosed in an MRI-based surveillance program
    Pål Møller, Astrid Tenden Stormorken, Christoffer Jonsrud, Marit Muri Holmen, Anne Irene Hagen, Neal Clark, Anita Vabø, Ping Sun, Steven Alexander Narod, Lovise Mæhle · 2013 · Breast Cancer Research and Treatment
  89. Formal and Informal Support Needs of Young Women withBRCAMutations
    Allison Werner‐Lin · 2008 · Journal of Psychosocial Oncology
  90. Genetic alterations in hereditary breast cancer
    Giovanna Cipollini, Stefania Tommasi, Angelo Paradiso, Paolo Aretini, Fabrizia Bonatti, Isa Maura Brunetti, M. Bruno, Giovanni Lombardi, Francesco Schittulli, Elisa Sensi et al. · 2004 · Annals of Oncology
  91. Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Medellín, Colombia
    Julián Esteban Londoño Hernández, Marcia Llacuachaqui, Gonzálo Vásquez Palacio, Juan David Figueroa, Jorge Madrid, Mauricio Lema, Robert Royer, Song Li, Garrett P. Larson, Jeffrey N. Weitzel et al. · 2014 · Hereditary Cancer in Clinical Practice
  92. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients
    Al-Joharah Alhuqail, Areej Alzahrani, Hannah Faisal Almubarak, Sarah Alqadheeb, Lamyaa Alghofaili, Nisreen Al‐Moghrabi, Hamed Alhusaini, Ben Ho Park, Dilek Çolak, Bedri Karakas · 2018 · Breast Cancer Research and Treatment
  93. DNA damage response and repair in ovarian cancer: Potential targets for therapeutic strategies
    Mohammad Mirza‐Aghazadeh‐Attari, Caspian Ostadian, Amir Ata Saei, Ainaz Mihanfar, Saber Ghazizadeh Darband, Shirin Sadighparvar, Mojtaba Kaviani, Hossein Samadi Kafil, Bahman Yousefi, Maryam Majidinia · 2019 · DNA repair
  94. BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study
    Tone Bjørge, Agnes Kathrine Lie, Eivind J. Hovig, Randi Elin Gislefoss, S Hansen, Egil Jellum, Hilde Langseth, Kjell Nustad, Claes G. Tropé, Anne Dørum · 2004 · British Journal of Cancer
  95. 2–47 Minority Recruitment in Hereditary Breast Cancer Research
    Chanita Hughes, Susan K. Peterson, Amelie G. Ramírez, Kipling J. Gallion, Paige Green McDonald, Celette Sugg Skinner, Deborah J. Bowen · 2005 · Breast Diseases A Year Book Quarterly
  96. Ovarian cancer and genetic susceptibility in relation to the BRCA1 and BRCA2 genes. Occurrence, clinical importance and intervention
    Marie Søgaard, Susanne K. Kjær, Simon A. Gayther · 2006 · Acta Obstetricia Et Gynecologica Scandinavica
  97. BRCA 1 and BRCA 2 mutations in J apanese patients with ovarian, fallopian tube, and primary peritoneal cancer
    Ikuko Sakamoto, Yosuke Hirotsu, Hiroshi Nakagomi, Hidetaka Ouchi, Atsushi Ikegami, Katsuhiro TERAMOTO, Kenji Amemiya, Hitoshi Mochizuki, Masao Omata · 2015 · Cancer
  98. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study
    Frank Qian, Shengfeng Wang, Jonathan S. Mitchell, Lesley McGuffog, Daniel Barrowdale, Goska Leslie, Jan C. Oosterwijk, Wendy K. Chung, D. Gareth Evans, Christoph Engel et al. · 2018 · JNCI Journal of the National Cancer Institute
  99. Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis
    Carolyn M. Cullinane, Ben Creavin, Emer O’Connell, L Kelly, Martin J. O’Sullivan, Mark Anthony Corrigan, Henry Paul Redmond · 2020 · British journal of surgery
  100. Genetic Testing for Inherited Breast Cancer Risk in African Americans
    Chanita Hughes Halbert, Lisa Jay Kessler, Edith Peterson Mitchell · 2005 · Cancer Investigation